OTCMKTS:ZMTP

Zoom Telephonics (ZMTP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$3.56
$3.79
50-Day Range
$0.09
$2.31
52-Week Range
$0.67
$3.50
Volume
14,767 shs
Average Volume
26,928 shs
Market Capitalization
$89.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ZMTP stock logo

About Zoom Telephonics Stock (OTCMKTS:ZMTP)

Zoom Telephonics, Inc., together with its subsidiary, designs, produces, markets, sells, and supports Internet access and other communications-related products in North America and internationally. It provides cable modems and gateways, multimedia over coax adapters, digital subscriber line modems, mobile broadband modems and routers, dial-up modems, local area network products, mobile broadband sensors, wireless and wired networking equipment, phone jacks and AC power adapters, and language-related specifics. The company sells its products through retailers and distributors, Internet and telephone service providers, value-added resellers, PC system integrators, and original equipment manufacturers, as well as through a direct sales force and independent sales agents. ZoomTelephonics, Inc. was founded in 1977 and is headquartered in Boston, Massachusetts.

ZMTP Stock News Headlines

His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
Zoom launches Zoom Workplace in AWS Marketplace
Zoom sees sales boom amid pandemic
His win rate puts Warren Buffett to shame…
Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.
16 Tips for Interviewing via Zoom
Zoom Telephonics earnings: here's what Wall Street expects
Snom D7XX VoIP Phones Now Zoom-Certified
Webex vs. Zoom: Which Is Best For Your Team?
See More Headlines
Receive ZMTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zoom Telephonics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/03/2018
Today
4/29/2024

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:ZMTP
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Net Income
$-3,280,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$37.61 million
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$89.50 million
Optionable
Not Optionable
Beta
0.13
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Jeremy P. Hitchcock (Age 38)
    Exec. Chairman & Interim Principal Exec. Officer
    Comp: $1.25k
  • Mr. Joseph Lee Wytanis (Age 60)
    Advisor
    Comp: $375.25k
  • Ms. Jacquelyn Barry Hamilton (Age 58)
    Chief Financial Officer
  • Mr. Philip Stanhope (Age 56)
    VP of Engineering & CTO
  • Ms. Alla Berina (Age 58)
    VP of Sales
  • Mr. John Lauten (Age 54)
    Sr. VP of Operations

ZMTP Stock Analysis - Frequently Asked Questions

How were Zoom Telephonics' earnings last quarter?

Zoom Telephonics, Inc. (OTCMKTS:ZMTP) released its earnings results on Thursday, May, 3rd. The technology company reported $0.02 earnings per share for the quarter. The technology company had revenue of $8.34 million for the quarter. Zoom Telephonics had a negative trailing twelve-month return on equity of 32.80% and a negative net margin of 8.31%.

What other stocks do shareholders of Zoom Telephonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zoom Telephonics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Digital Ally (DGLY), iBio (IBIO), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), SANUWAVE Health (SNWV), Sierra Oncology (SRRA) and T2 Biosystems (TTOO).

This page (OTCMKTS:ZMTP) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners